Forbes -
10 Sep 2020 14:00

Emergent Biosolutions stock has rallied 111% since late March (vs. about 53% for the S&P 500) to its current level around $105. The stock fell to a low of $50 in late March when a rapid increase in the number Covid-19 cases outside China resulted in heightened fears of an imminent global economic...
Share this Article
Comment on this Article
Please to comment